Elder n = 10 | Younger n = 38 | P value | |
---|---|---|---|
Age | 83 ± 2.8 | 66 ± 7.2 | <0.0001 |
Gender (male/female) | 7/3 | 28/10 | |
BMI | 21.6 ± 3.8 | 22.9 ± 3.6 | N.S. |
eGFR (ml/min/1.73 m2) | 56.3 ± 13.9 | 70.6 ± 19.7 | 0.014 |
%VC, % | 109 ± 20 | 105 ± 18.1 | N.S. |
ASA class (1/2) | 0/10 | 13/25 | 0.028 |
Performance status (0/1) | 8/2 | 38/0 | |
Comorbidity | |||
Hypertension, n (%) | 2 (20) | 6 (15.7) | |
Ischemic heart disease, n (%) | 1 (10) | 1 (2.6) | |
Arrhythmia, n (%) | 1 (10) | 1 (2.6) | |
Diabetes mellitus, n (%) | 0 | 3 (7.8) | |
Chronic hepatitis C, n (%) | 1 (10) | 1 (2.6) | |
NASH, n (%) | 0 | 1 (2.6) | |
History of renal cancer, n (%) | 1 (10) | 1 (2.6) | |
End-stage renal failure, n (%) | 0 | 1 (2.6) | |
History of cerebral infarction, n (%) | 0 | 5 (13.1) | |
Dementia, n (%) | 1 (10) | 0 |